171 related articles for article (PubMed ID: 8406359)
1. Disordered hemostasis in extrahepatic portal hypertension.
Robson SC; Kahn D; Kruskal J; Bird AR; Kirsch RE
Hepatology; 1993 Oct; 18(4):853-7. PubMed ID: 8406359
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
[TBL] [Abstract][Full Text] [Related]
3. Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis.
Bajaj JS; Bhattacharjee J; Sarin SK
J Gastroenterol Hepatol; 2001 Jun; 16(6):641-6. PubMed ID: 11422617
[TBL] [Abstract][Full Text] [Related]
4. A comparative clinical study of idiopathic portal hypertension, extrahepatic portal vein thrombosis, and cirrhosis.
Orozco H; Takahashi T; Garcia-Tsao G; Mercado MA; Prado E; Nava R
J Clin Gastroenterol; 1994 Oct; 19(3):217-21. PubMed ID: 7806833
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic changes in patients with liver cirrhosis.
Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
[TBL] [Abstract][Full Text] [Related]
6. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
[TBL] [Abstract][Full Text] [Related]
7. Outcome of injection sclerotherapy using absolute alcohol in patients with cirrhosis, non-cirrhotic portal fibrosis, and extrahepatic portal venous obstruction.
Kochhar R; Goenka MK; Mehta SK
Gastrointest Endosc; 1991; 37(4):460-4. PubMed ID: 1916169
[TBL] [Abstract][Full Text] [Related]
8. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
9. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
11. Relation of serum levels of thrombopoietin to thrombocytopenia in extrahepatic portal vein obstruction versus cirrhotic children.
El-Sayed R; El-Ela MA; El-Raziky MS; Helmy H; El-Ghaffar AA; El-Karaksy H
J Pediatr Hematol Oncol; 2011 Oct; 33(7):e267-70. PubMed ID: 21941130
[TBL] [Abstract][Full Text] [Related]
12. Experience with the Rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension.
Bambini DA; Superina R; Almond PS; Whitington PF; Alonso E
J Pediatr Surg; 2000 Jan; 35(1):13-8; discussion 18-9. PubMed ID: 10646766
[TBL] [Abstract][Full Text] [Related]
13. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
16. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes.
Basili S; Raparelli V; Violi F
Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871
[TBL] [Abstract][Full Text] [Related]
17. Review article: The management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults.
Spaander VM; van Buuren HR; Janssen HL
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():203-9. PubMed ID: 18081663
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
19. The coagulation system in patients with end-stage liver disease.
Valla DC; Rautou PE
Liver Int; 2015 Jan; 35 Suppl 1():139-44. PubMed ID: 25529099
[TBL] [Abstract][Full Text] [Related]
20. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding.
Maruyama H; Takahashi M; Shimada T; Yokosuka O
Scand J Gastroenterol; 2012 Jun; 47(6):686-91. PubMed ID: 22472055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
